PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 135 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $20,433,000 | -45.1% | 455,276 | -68.3% | 0.09% | -44.1% |
| Q1 2021 | $37,197,000 | +28.5% | 1,436,192 | 0.0% | 0.16% | +47.7% |
| Q4 2020 | $28,954,000 | -7.2% | 1,436,192 | -10.0% | 0.11% | -12.8% |
| Q3 2020 | $31,206,000 | -7.6% | 1,596,198 | -16.5% | 0.12% | -16.1% |
| Q2 2020 | $33,756,000 | +184.7% | 1,911,446 | +13.8% | 0.15% | +104.1% |
| Q1 2020 | $11,855,000 | +43.2% | 1,679,164 | +43.0% | 0.07% | +65.9% |
| Q4 2019 | $8,279,000 | -41.3% | 1,174,282 | 0.0% | 0.04% | -54.2% |
| Q3 2019 | $14,103,000 | +17.0% | 1,174,282 | +18.0% | 0.10% | +17.1% |
| Q2 2019 | $12,050,000 | +137.3% | 995,082 | +146.4% | 0.08% | +156.2% |
| Q1 2019 | $5,077,000 | – | 403,893 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |